Dyadic International Inc - Understand $dyai stock

$DYAI Market Cap: $34.19 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$1.804M

TTM

Gross Margin

50.27%

TTM

Net Earnings

-$7.741M

TTM

Current Assets

$10.50M

Q2 2024

Current Liabilities

$1.949M

Q2 2024

Current Ratio

539.01%

Q2 2024

Total Assets

$10.63M

Q2 2024

Total Liabilities

$7.462M

Q2 2024

Book Value

$3.168M

Q2 2024

Cash

$6.133M

Q2 2024

P/E

-4.417

Sep 18, 2024 EST

Free Cash Flow

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$2.899M	$2.930M	$2.404M	$1.602M	$1.681M	$1.295M	$758.4K	$590.0K	$320.0K	$12.52M	$17.13M	$15.60M	$10.25M	$8.440M	$21.42M	$13.12M	$13.28M	$15.38M	$15.88M	$16.74M	$16.78M	$10.03M
YoY Change	-1.07%	21.9%	50.06%	-4.71%	29.77%	70.81%	28.55%	84.38%	-97.44%	-26.91%	9.81%	52.2%	21.45%	-60.6%	63.26%	-1.2%	-13.65%	-3.15%	-5.14%	-0.24%	67.3%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$2.899M	$2.930M	$2.404M	$1.602M	$1.681M	$1.295M	$758.4K	$590.0K	$320.0K	$12.52M	$17.13M	$15.60M	$10.25M	$8.440M	$21.42M	$13.12M	$13.28M	$15.38M	$15.88M	$16.74M	$16.78M	$10.03M
Cost Of Revenue	$1.976M	$2.123M	$1.944M	$1.425M	$1.460M	$1.027M	$680.2K	$520.0K	$120.0K	$8.180M	$9.720M	$7.620M	$6.640M	$6.500M	$6.290M	$9.110M	$8.520M	$11.35M	$12.86M	$12.83M	$12.60M	$7.990M
Gross Profit	$923.0K	$807.1K	$459.4K	$177.0K	$221.4K	$268.2K	$78.22K	$80.00K	$190.0K	$4.350M	$7.410M	$7.990M	$3.610M	$1.940M	$15.13M	$4.000M	$4.760M	$4.040M	$3.030M	$3.910M	$4.180M	$2.040M
Gross Profit Margin	31.84%	27.54%	19.11%	11.05%	13.17%	20.7%	10.31%	13.56%	59.38%	34.74%	43.26%	51.22%	35.22%	22.99%	70.63%	30.49%	35.84%	26.27%	19.08%	23.36%	24.91%	20.34%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Selling, General & Admin	$5.817M	$6.422M	$6.698M	$6.080M	$5.520M	$4.520M	$5.030M	$4.560M	$3.840M	$7.350M	$5.930M	$5.490M	$6.760M	$6.150M	$5.290M	$12.08M	$11.63M	$10.57M	$8.130M	$5.610M	$4.060M	$3.560M
YoY Change	-9.41%	-4.12%	10.16%	10.14%	22.12%	-10.14%	10.31%	18.75%	-47.76%	23.95%	8.01%	-18.79%	9.92%	16.26%	-56.21%	3.87%	10.03%	30.01%	44.92%	38.18%	14.04%
% of Gross Profit	630.26%	795.62%	1457.93%	3435.22%	2493.51%	1685.48%	6430.33%	5700.0%	2021.05%	168.97%	80.03%	68.71%	187.26%	317.01%	34.96%	302.0%	244.33%	261.63%	268.32%	143.48%	97.13%	174.51%
Research & Development	$3.297M	$4.501M	$8.392M	$3.868M	$3.088M	$2.102M	$1.765M	$890.0K	$0.00	$2.190M	$1.000M	$920.0K	$1.050M	$1.240M	$1.210M	$4.100M	$5.010M	$4.240M	$4.900M	$3.620M	$3.570M	$3.140M
YoY Change	-26.75%	-46.36%	116.96%	25.28%	46.91%	19.04%	98.37%		-100.0%	119.0%	8.7%	-12.38%	-15.32%	2.48%	-70.49%	-18.16%	18.16%	-13.47%	35.36%	1.4%	13.69%
% of Gross Profit	357.25%	557.71%	1826.84%	2185.5%	1394.74%	783.68%	2256.98%	1112.5%	0.0%	50.34%	13.5%	11.51%	29.09%	63.92%	8.0%	102.5%	105.25%	104.95%	161.72%	92.58%	85.41%	153.92%
Depreciation & Amortization									$0.00	$270.0K	$250.0K	$250.0K	$290.0K	$330.0K	$300.0K	$340.0K	$270.0K	$300.0K	$610.0K	$590.0K	$580.0K	$190.0K
YoY Change									-100.0%	8.0%	0.0%	-13.79%	-12.12%	10.0%	-11.76%	25.93%	-10.0%	-50.82%	3.39%	1.72%	205.26%
% of Gross Profit									0.0%	6.21%	3.37%	3.13%	8.03%	17.01%	1.98%	8.5%	5.67%	7.43%	20.13%	15.09%	13.88%	9.31%
Operating Expenses	$9.114M	$4.501M	$8.392M	$3.868M	$3.088M	$2.102M	$1.765M	$5.880M	$3.840M	$9.540M	$6.940M	$6.430M	$7.810M	$7.380M	$6.500M	$16.19M	$16.64M	$14.80M	$13.03M	$9.240M	$7.630M	$6.710M
YoY Change	102.48%	-46.36%	116.96%	25.28%	46.91%	19.04%	-69.97%	53.13%	-59.75%	37.46%	7.93%	-17.67%	5.83%	13.54%	-59.85%	-2.7%	12.43%	13.58%	41.02%	21.1%	13.71%
Operating Profit	-$8.191M	-$10.17M	-$14.73M	-$10.03M	-$9.283M	-$7.592M	-$7.127M	-$5.800M	-$3.650M	-$5.190M	$470.0K	$1.560M	-$4.200M	-$5.440M	$8.630M	-$12.19M	-$11.88M	-$10.76M	-$10.00M	-$5.330M	-$3.450M	-$4.670M
YoY Change	-19.42%	-30.97%	46.9%	8.01%	22.26%	6.53%	22.88%	58.9%	-29.67%	-1204.26%	-69.87%	-137.14%	-22.79%	-163.04%	-170.8%	2.61%	10.41%	7.6%	87.62%	54.49%	-26.12%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Interest Expense	$378.3K	$180.4K	$51.70K	$447.0K	$984.9K	$894.5K	$566.1K	$330.0K	$10.00K	-$810.0K	-$590.0K	-$670.0K	-$550.0K	-$340.0K	-$140.0K	-$260.0K	$800.0K	-$70.00K	-$450.0K	-$760.0K	-$3.740M	-$70.00K
YoY Change	109.66%	248.95%	-88.43%	-54.62%	10.11%	58.0%	71.56%	3200.0%	-101.23%	37.29%	-11.94%	21.82%	61.76%	142.86%	-46.15%	-132.5%	-1242.86%	-84.44%	-40.79%	-79.68%	5242.86%
% of Operating Profit											-125.53%	-42.95%			-1.62%
Other Income/Expense, Net	$1.434M	$430.4K	$1.657M	$731.7K		$894.5K	$4.924M						$0.00	-$160.0K	$0.00	$80.00K	$480.0K	$20.00K	$0.00	$20.00K	$10.00K	-$40.00K
YoY Change	233.23%	-74.03%	126.49%			-81.83%							-100.0%		-100.0%	-83.33%	2300.0%		-100.0%	100.0%	-125.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Pretax Income	-$6.795M	-$9.828M	-$13.12M	-$9.246M	-$8.275M	-$6.623M	-$2.097M	-$3.370M	-$1.470M	-$5.980M	-$430.0K	$1.420M	-$4.740M	-$5.530M	$5.240M	-$12.37M	-$15.50M	-$10.82M	-$10.45M	-$6.070M	-$7.170M	-$4.770M
YoY Change	-30.86%	-25.06%	41.85%	11.74%	24.94%	215.83%	-37.78%	129.25%	-75.42%	1290.7%	-130.28%	-129.96%	-14.29%	-205.53%	-142.36%	-20.19%	43.25%	3.54%	72.16%	-15.34%	50.31%
Income Tax			$0.00	$31.32K	$10.31K	-$1.006M	-$66.69K	$240.0K		$0.00	$0.00	$70.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$60.00K	$60.00K	$10.00K	$90.00K	$40.00K
% Of Pretax Income												4.93%			0.0%
Net Earnings	-$6.795M	-$9.735M	-$13.07M	-$9.325M	-$8.308M	-$5.692M	-$2.136M	-$3.610M	$65.79M	-$5.980M	-$430.0K	$1.350M	-$4.740M	-$5.530M	$5.240M	-$12.37M	-$15.50M	-$10.88M	-$10.52M	-$6.080M	-$7.260M	-$4.820M
YoY Change	-30.2%	-25.52%	40.16%	12.24%	45.96%	166.49%	-40.84%	-105.49%	-1200.17%	1290.7%	-131.85%	-128.48%	-14.29%	-205.53%	-142.36%	-20.19%	42.46%	3.42%	73.03%	-16.25%	50.62%
Net Earnings / Revenue	-234.42%	-332.23%	-543.73%	-582.13%	-494.21%	-439.36%	-281.61%	-611.86%	20559.38%	-47.76%	-2.51%	8.65%	-46.24%	-65.52%	24.46%	-94.28%	-116.72%	-70.74%	-66.25%	-36.32%	-43.27%	-48.06%
Basic Earnings Per Share	-$0.24	-$0.34	-$0.47
Diluted Earnings Per Share	-$0.24	-$0.34	-$469.5K	-$339.6K	-$307.8K	-$205.6K	-$74.00K	-$98.80K	$1.914M	-$175.5K	-$13.11K	$39.44K	-$151.2K	-$178.3K	$157.7K	-$412.5K	-$517.4K	-$445.5K	-$475.4K	-$372.5K	-$582.7K	-$386.8K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Cash & Short-Term Investments	$7.263M	$12.64M	$20.26M	$29.09M	$34.22M	$41.20M	$47.69M	$48.94M	$68.60M	$2.500M	$8.890M	$3.990M	$3.690M	$4.540M	$8.420M	$2.830M	$15.95M	$31.07M	$12.15M	$20.51M	$1.650M
YoY Change	-42.54%	-37.6%	-30.35%	-14.99%	-16.94%	-13.61%	-2.55%	-28.66%	2644.0%	-71.88%	122.81%	8.13%	-18.72%	-46.08%	197.53%	-82.26%	-48.66%	155.72%	-40.76%	1143.03%
Cash & Equivalents	$6.515M	$5.794M	$15.75M	$20.64M	$4.820M	$2.390M	$5.790M	$6.890M	$68.60M	$2.500M	$8.890M	$3.990M	$3.690M	$4.540M	$8.420M	$2.830M	$15.95M	$31.07M	$12.15M	$20.51M	$1.650M
Short-Term Investments	$748.3K	$6.847M	$4.512M	$8.460M	$29.40M	$38.82M	$41.90M	$42.05M
Other Short-Term Assets	$327.8K	$392.2K	$375.8K	$280.0K	$100.0K	$430.0K	$1.170M	$7.600M	$490.0K	$6.030M	$370.0K	$430.0K	$490.0K	$590.0K	$740.0K	$980.0K	$1.140M	$1.170M	$850.0K	$830.0K	$280.0K
YoY Change	-16.43%	4.37%	34.23%	180.0%	-76.74%	-63.25%	-84.61%	1451.02%	-91.87%	1529.73%	-13.95%	-12.24%	-16.95%	-20.27%	-24.49%	-14.04%	-2.56%	37.65%	2.41%	196.43%
Inventory											$2.800M	$2.770M	$3.280M	$2.780M	$2.820M	$3.780M	$6.120M	$6.040M	$5.410M	$6.640M	$4.550M
Prepaid Expenses
Receivables	$466.2K	$330.0K	$277.8K	$290.0K	$560.0K	$320.0K	$270.0K	$590.0K	$80.00K		$1.680M	$1.260M	$1.770M	$1.280M	$1.380M	$1.500M	$1.410M	$2.790M	$2.870M	$3.080M	$3.690M
Other Receivables	$10.08K	$58.29K	$94.38K	$120.0K	$750.0K	$800.0K	$490.0K	$490.0K	$0.00		$110.0K	$3.500M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$8.067M	$13.42M	$21.01M	$29.78M	$35.64M	$42.75M	$49.62M	$57.63M	$69.17M	$8.520M	$13.85M	$11.95M	$9.240M	$9.180M	$13.35M	$9.090M	$24.63M	$41.07M	$21.27M	$31.06M	$10.17M
YoY Change	-39.89%	-36.11%	-29.46%	-16.44%	-16.63%	-13.85%	-13.9%	-16.68%	711.85%	-38.48%	15.9%	29.33%	0.65%	-31.24%	46.86%	-63.09%	-40.03%	93.09%	-31.52%	205.41%
Property, Plant & Equipment	$141.4K										$500.0K	$390.0K	$550.0K	$720.0K	$840.0K	$1.040M	$1.190M	$1.810M	$1.730M	$800.0K	$1.200M
YoY Change											28.21%	-29.09%	-23.61%	-14.29%	-19.23%	-12.61%	-34.25%	4.62%	116.25%	-33.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$284.7K	$284.7K	$280.0K	$1.510M	$0.00	$920.0K	$1.070M
YoY Change	-100.0%	0.0%	1.68%	-81.46%		-100.0%	-14.02%
Other Assets	$10.46K	$6.050K	$6.120K	$10.00K	$50.00K	$50.00K	$210.0K	$10.00K	$7.500M	$10.00K	$20.00K	$20.00K	$20.00K	$20.00K	$20.00K	$140.0K		$350.0K	$130.0K	$200.0K	$260.0K
YoY Change	72.89%	-1.14%	-38.8%	-80.0%	0.0%	-76.19%	2000.0%	-99.87%	74900.0%	-50.0%	0.0%	0.0%	0.0%	0.0%	-85.71%			169.23%	-35.0%	-23.08%
Total Long-Term Assets	$151.9K	$290.8K	$290.8K	$290.0K	$1.810M	$550.0K	$1.120M	$1.070M	$7.500M	$20.00K	$1.090M	$930.0K	$1.060M	$1.050M	$1.010M	$1.340M	$1.460M	$4.070M	$2.480M	$1.660M	$2.180M
YoY Change	-47.76%	-0.02%	0.28%	-83.98%	229.09%	-50.89%	4.67%	-85.73%	37400.0%	-98.17%	17.2%	-12.26%	0.95%	3.96%	-24.63%	-8.22%	-64.13%	64.11%	49.4%	-23.85%
Total Assets	$8.219M	$13.71M	$21.30M	$30.07M	$37.45M	$43.30M	$50.74M	$58.70M	$76.67M	$8.540M	$14.94M	$12.88M	$10.30M	$10.23M	$14.36M	$10.43M	$26.09M	$45.14M	$23.75M	$32.72M	$12.35M
YoY Change
Accounts Payable						$310.0K	$520.0K	$280.0K	$630.0K	$500.0K	$2.570M	$1.690M	$2.040M	$1.800M	$1.950M	$2.680M	$1.940M	$2.240M	$2.600M	$2.960M	$2.490M
YoY Change						-40.38%	85.71%	-55.56%	26.0%	-80.54%	52.07%	-17.16%	13.33%	-7.69%	-27.24%	38.14%	-13.39%	-13.85%	-12.16%	18.88%
Accrued Expenses	$1.105M	$955.1K	$709.6K	$490.0K	$570.0K	$400.0K	$150.0K	$390.0K	$2.110M	$380.0K	$640.0K	$410.0K	$610.0K	$560.0K	$4.020M	$520.0K	$1.570M	$1.850M	$1.440M	$1.560M	$1.270M
YoY Change	15.72%	34.6%	44.81%	-14.04%	42.5%	166.67%	-61.54%	-81.52%	455.26%	-40.63%	56.1%	-32.79%	8.93%	-86.07%	673.08%	-66.88%	-15.14%	28.47%	-7.69%	22.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.420M	$1.420M	$1.420M	$1.420M	$2.430M	$2.410M	$190.0K	$270.0K	$0.00	$0.00
YoY Change											-100.0%	0.0%	0.0%	0.0%	-41.56%	0.83%	1168.42%	-29.63%
Long-Term Debt Due																			$170.0K	$170.0K	$330.0K
YoY Change																			0.0%	-48.48%
Total Short-Term Liabilities	$2.252M	$2.449M	$2.556M	$1.630M	$1.590M	$850.0K	$770.0K	$1.010M	$2.870M	$2.660M	$4.130M	$4.090M	$4.100M	$3.790M	$7.400M	$8.970M	$9.260M	$4.410M	$4.640M	$4.860M	$4.140M
YoY Change	-8.04%	-4.19%	56.79%	2.52%	87.06%	10.39%	-23.76%	-64.81%	7.89%	-35.59%	0.98%	-0.24%	8.18%	-48.78%	-17.5%	-3.13%	109.98%	-4.96%	-4.53%	17.39%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$8.140M	$8.240M	$7.000M	$7.000M	$4.000M	$0.00	$0.00	$0.00	$2.380M	$3.630M	$3.260M	$5.870M
YoY Change									-100.0%	-1.21%	17.71%	0.0%	75.0%				-100.0%	-34.44%	11.35%	-44.46%
Other Long-Term Liabilities	$88.87K	$176.5K	$352.9K														$3.330M	$10.16M	$110.0K	$40.00K
YoY Change	-49.64%	-50.0%															-67.22%	9136.36%	175.0%
Total Long-Term Liabilities	$88.87K	$176.5K	$352.9K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$8.140M	$8.240M	$7.000M	$7.000M	$4.000M	$0.00	$0.00	$3.330M	$12.54M	$3.740M	$3.300M	$5.870M
YoY Change	-49.64%	-50.0%							-100.0%	-1.21%	17.71%	0.0%	75.0%			-100.0%	-73.44%	235.29%	13.33%	-43.78%
Total Liabilities	$2.341M	$2.625M	$2.909M	$1.630M	$1.590M	$850.0K	$770.0K	$1.010M	$2.870M	$10.80M	$12.37M	$11.09M	$11.10M	$7.790M	$7.400M	$8.970M	$12.59M	$16.95M	$8.480M	$8.260M	$10.10M
YoY Change	-10.84%	-9.75%	78.45%	2.52%	87.06%	10.39%	-23.76%	-64.81%	-73.43%	-12.69%	11.54%	-0.09%	42.49%	5.27%	-17.5%	-28.75%	-25.72%	99.88%	2.66%	-18.22%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022
Basic Shares Outstanding	28.80M	28.36M
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $34.194 Million

About Dyadic International Inc

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. The company is headquartered in Jupiter, Florida and currently employs 7 full-time employees. The company went IPO on 2004-11-05. The firm's gene expression and protein production platforms are based on the highly productive and scalable fungus Thermothelomyces heterothallica (formerly Myceliophthora thermophila). Its lead technology, C1-cell protein production platform, is based on an industrially proven microorganism (named C1), which is used to speed development and improve performance of biologic vaccines and drugs at flexible commercial scales for the human and animal health markets. The firm has also developed the Dapibus filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of low-cost proteins, metabolites, and other biologic products for use in non-pharmaceutical applications.

Industry: Biological Products, (No Diagnostic Substances) Peers: Applied Therapeutics Inc Quince Therapeutics Inc Exagen Inc Immunome Inc Lantern Pharma Inc MERRIMACK PHARMACEUTICALS INC Minerva Neurosciences Inc Mustang Bio Inc Synaptogenix Inc